User Community

Advertisement

Quality Experts
@quality-experts
Trusted Member
Joined: Apr 15, 2025
Last seen: Apr 17, 2026
Topics: 0 / Replies: 75
Reply
RE: Data integrity in biologics manufacturing

Ensure that all systems generating or storing manufacturing data are validated, secure, and audit trail enabled. Data used for release decisions or in...

3 days ago
Reply
RE: Real-time decision-making for biopharma manufacturing

Integrated monitoring systems, timely availability of process and quality data, and clear deviation management procedures. Advanced process monitoring...

3 days ago
Reply
RE: Reducing risk of batch failures in biopharma manufacturing

Perform thorough process characterisation and define proven acceptable ranges for critical process parameters. Scale dependent effects such as mixing,...

3 days ago
Reply
RE: Emerging regulatory expectations for biologics manufacturing

Increasing emphasis on contamination control, especially for sterile products. Regulators expect a comprehensive strategy covering facility design, ut...

3 days ago
Reply
RE: Documentation practices that improve regulator's confidence

Maintain clear traceability between development knowledge, risk assessments, process decisions, and the control strategy. Regulators value structured ...

3 days ago
Reply
RE: Post approval changes without regulatory delays

Establish a lifecycle management strategy early. Define which changes can be managed within the Pharmaceutical Quality System and which require regula...

3 days ago
Reply
RE: Common weakness regulators see in CMC sections for biologics

Insufficient demonstration of process consistency and product comparability across development stages. Changes in cell line, scale, or process can aff...

3 days ago
Reply
RE: How can companies ensure that quality is designed into a biologics product and process early?

Start with a structured Quality by Design approach. Define the Quality Target Product Profile (QTPP), identify Critical Quality Attributes (CQAs), and...

3 days ago
Reply
RE: Commercial databases accepted for GMP analyses

Even though (CHO) protein databases are available, it is of added value to thoroughly analyse the pool of proteins expressed by the host cells used to...

3 days ago
Reply
RE: Commercial databases accepted for GMP analyses

The proteome protein databases can be downloaded from NCBI or Uniprot for all common expression systems. For GMP the database should be locked. Ejvi...

3 days ago
Reply
RE: Risk analysis of ELISA only vs orthogonal analysis?.

That depends on the situation, for example: what expression system are you using? How well is your process clearing residual host cell proteins, are t...

3 days ago
Reply
RE: GMP LCMS HCP analysis

It is not needed to perform LC-MS-based HCP analysis in a GMP environment: in most cases, ELISA-based analysis works fine (and is accepted). The fact ...

3 days ago
Reply
RE: GMP LCMS HCP analysis

In some cases it is an advantage to do GMP LC-MS analysis. E.g. when no suitable ELISA is available and it takes 2 years, a lot of money, and assay de...

3 days ago
Reply
RE: Best practice methods in USP 1132.1, and certified reference standards for calibration

Use best practice methods in USP 1132.1, and certified reference standards for calibration. Ejvind Mørtz, PhD, Co-Founder & COO of Alphalyse in ...

3 days ago
Reply
RE: Best approach to generate a suitable database for LC-MS quantitation and ID

The proteome protein sequences can be downloaded from NCBI and Uniprot for all common expression systems, and most exotic expression systems as well. ...

3 days ago
Page 1 / 5

Advertisement

Advertisement

Advertisement